Black Diamond Therapeutics, Inc. (BDTX)
1.805
-0.14
(-6.96%)
USD |
NASDAQ |
Oct 06, 16:00
1.805
0.00 (0.00%)
After-Hours: 18:30
Black Diamond Therapeutics Market Cap : 103.69M for Oct. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 05, 2026 | 111.45M |
| October 02, 2026 | 108.57M |
| October 01, 2026 | 108.00M |
| September 30, 2026 | 108.29M |
| September 29, 2026 | 107.42M |
| September 28, 2026 | 105.13M |
| September 25, 2026 | 108.00M |
| September 24, 2026 | 108.57M |
| September 23, 2026 | 109.15M |
| September 22, 2026 | 113.74M |
| September 21, 2026 | 112.02M |
| September 18, 2026 | 112.59M |
| September 17, 2026 | 110.87M |
| September 16, 2026 | 111.45M |
| September 15, 2026 | 113.17M |
| September 14, 2026 | 116.62M |
| September 11, 2026 | 113.74M |
| September 10, 2026 | 112.59M |
| September 09, 2026 | 120.64M |
| September 08, 2026 | 120.64M |
| September 04, 2026 | 121.79M |
| September 03, 2026 | 120.64M |
| September 02, 2026 | 122.94M |
| September 01, 2026 | 117.19M |
| August 31, 2026 | 120.64M |
| Date | Value |
|---|---|
| August 28, 2026 | 128.11M |
| August 27, 2026 | 130.40M |
| August 26, 2026 | 130.40M |
| August 25, 2026 | 128.68M |
| August 24, 2026 | 123.80M |
| August 21, 2026 | 126.96M |
| August 20, 2026 | 123.51M |
| August 19, 2026 | 125.81M |
| August 18, 2026 | 118.34M |
| August 17, 2026 | 117.76M |
| August 14, 2026 | 116.04M |
| August 13, 2026 | 116.04M |
| August 12, 2026 | 120.64M |
| August 11, 2026 | 120.06M |
| August 10, 2026 | 113.74M |
| August 07, 2026 | 112.02M |
| August 06, 2026 | 110.30M |
| August 05, 2026 | 102.83M |
| August 04, 2026 | 102.25M |
| August 03, 2026 | 99.67M |
| July 31, 2026 | 96.84M |
| July 30, 2026 | 98.27M |
| July 29, 2026 | 95.12M |
| July 28, 2026 | 100.85M |
| July 27, 2026 | 99.13M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 318.76M |
| Amgen, Inc. | 217.73B |
| BioCryst Pharmaceuticals, Inc. | 2.031B |
| Imunon, Inc. | 5.366M |
| Curis, Inc. | 1.470M |
Market Cap Related Metrics
| Price to Book Value | 1.079 |
| Price | 1.805 |
| Earnings Yield | -41.26% |